|
|
 | | | |
- close
- close
- close
- close
Eisai Co. Ltd. (ESALY) |
MedPage Today
Jun 18
Comment
SYDNEY (MedPage Today) -- Parkinson's disease patients who have impaired cognition appeared to benefit from the Alzheimer's disease medicine donepezil (Aricept) with no detriment to their motor skills, researchers reported here.
JCN Network
Jun 17
Comment
Eisai Co., Ltd. announced today that it has decided to further invest at its Hatfield, Hertfordshire production plant in the United Kingdom in creation of an additional packaging facility ahead of plans to launch multiple new Eisai products.
JCN Network
Jun 10
Comment
Eisai Co., Ltd. announced today that the therapeutic effects of lenvatinib (generic name; VEGF receptor tyrosine kinase inhibitor and multi-kinase inhibitor discovered in-house) on melanoma have been confirmed in one of a series of joint...
JCN Network
Jun 3
Comment
Eisai Co., Ltd. announced today at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO) new findings showing that Halaven(R) (eribulin mesylate, "eribulin") improved overall quality of life (QOL) (Global Health Status and...
JCN Network
May 28
Comment
Eisai Co., Ltd. announced today that it will launch antiepileptic agent Inovelon(R) Tablets 100 mg and 200 mg (rufinamide) in Japan on May 29 as an adjunctive therapy to other antiepileptic drugs (AEDs) in the treatment of Lennox-Gastaut syndrome...
Benzinga
May 7
Comment
Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) announced today that the Office of the Federal Register filed for public
inspection the US Drug Enforcement Administration's (DEA) final rule placing
BELVIQ ^ (pronounced BEL-VEEK) into Schedule IV of...
FiercePharma
Apr 25
Comment
Eisai is drawing a bigger target on China with plans for a new manufacturing plant near Suzhou. The Japanese drugmaker will use the plant to tap growing demand in that country, as well as an export base for other emerging markets in Asia. Report
Benzinga
Apr 24
Comment
GE (NYSE: GE) Healthcare today announced a research collaboration agreement with Eisai Inc. for use of the GE Healthcare investigational PET amyloid imaging agent, [18F]flutemetamol, to help select patients for a phase I clinical trial being...
Suggest other news sources for this topic
more ▼WIKI ANALYSIS
WIKI ANALYSIS|
Error creating thumbnail: convert: unable to open image `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png': No such file or directory @ blob.c/OpenBlob/2480. convert: unable to open file `/home/wikinvest/src_live_2/mediawiki/images/9/98/New_stock.png' @ png.c/ReadPNGImage/2889. convert: missing an image filename `/home/wikinvest/src_live_2/mediawiki/images/thumb/9/98/New_stock.png/35px-New_stock.png' @ convert.c/ConvertImageCommand/2800. |
The article on this company has not been written yet. If you're the first person to write this article, it's a sure thing that you'll be credited as a Top Contributor. For tips on getting started, check out the sample article. |
References
| |||||||
